Medical Cannabis for Hepatitis C: A Complete Patient & Caregiver Resource Guide

Hepatitis C can affect far more than your liver. Many patients struggle with fatigue, appetite changes, pain, sleep disruption, and emotional stress while trying to maintain daily routines. Some people explore cannabis as part of a symptom support plan after speaking with a medical marijuana clinic about safer products and responsible dosing.  This guide explains how medical cannabis may fit into hepatitis C care, what limitations patients should understand, and how to approach cannabis in a way that supports comfort while still prioritizing proper liver treatment and long-term health.

1. Start Here: What This Guide Is and Is Not

1.1 Who this guide is for

This guide is written for patients with hepatitis C, caregivers, family members, and people considering medical cannabis for symptom support. It explains possible benefits, risks, safety concerns, and treatment considerations in plain language so you can make informed decisions while continuing proper liver care and medical follow-up.

1.2 What medical cannabis may help with

Medical cannabis may help some hepatitis C patients manage symptoms that interfere with daily comfort and quality of life. Patients commonly ask about cannabis for nausea, reduced appetite, chronic pain, sleep problems, and anxiety related to illness or treatment. Certain products may also help some people feel calmer or more comfortable during periods of physical discomfort. Patients often discuss cannabis with healthcare professionals for concerns such as:

• Nausea and reduced appetite during treatment or chronic illness
• Difficulty sleeping because of discomfort or stress
• Chronic body aches and nerve-related discomfort
• Anxiety connected to long-term illness and medical treatment
• Problems maintaining healthy food intake and a stable weight

Cannabis affects every patient differently, especially when liver disease is involved. A product that helps one patient sleep may leave another feeling dizzy or anxious. Safe use starts with careful product selection, low dosing, and honest communication with healthcare professionals who understand your liver condition and medication history.

1.3 What cannabis cannot do

Cannabis cannot cure hepatitis C or remove the virus from the body. Current medical evidence supports antiviral medications as the proper treatment for clearing hepatitis C infection. Cannabis also cannot reverse advanced cirrhosis, repair severe liver scarring, or eliminate liver cancer risk in patients with chronic liver disease. Patients should also avoid products making claims about detoxifying, cleansing, or healing the liver naturally. These statements can delay effective medical treatment and create dangerous misunderstandings about hepatitis C care.  Feeling temporary symptom relief after cannabis use does not mean liver inflammation has improved or that the virus has disappeared. Even patients who feel physically better still need proper monitoring, blood work, and evidence-based treatment.

2. Hepatitis C Basics Every Patient Should Understand

2.1 What hepatitis C is

Hepatitis C is a viral infection that affects the liver and spreads through infected blood. Symptoms may take years to appear, so many people are diagnosed through routine testing. According to the Centers for Disease Control and Prevention, many people with hepatitis C do not experience symptoms for years, yet chronic infection can still lead to liver damage, cirrhosis, liver cancer, and other serious complications.  The virus can cause long-term liver inflammation and damage. Early diagnosis improves the chances of protecting liver function and preventing serious complications.

2.2 Acute vs chronic hepatitis C

Acute hepatitis C refers to the early stage of infection, usually during the first six months after exposure. Some patients naturally clear the virus during this period, but many develop chronic hepatitis C, meaning the infection stays active in the body long term and continues affecting the liver over many years. Key differences patients should understand include:

• Acute hepatitis C happens soon after infection and may cause mild or no symptoms
• Chronic hepatitis C develops when the virus remains in the body beyond six months
• Many patients with chronic hepatitis C feel healthy despite ongoing liver damage
• Long-term infection increases the risk of fibrosis, cirrhosis, and liver cancer
• Early diagnosis and treatment greatly improve long-term health outcomes

Because symptoms can remain mild for years, regular medical evaluation and blood work remain essential even when patients feel relatively well day to day.

2.3 How hepatitis C affects the liver over time

Long-term hepatitis C infection may gradually replace healthy liver tissue with scar tissue through a process called fibrosis. As scarring worsens, patients can develop cirrhosis, which significantly affects normal liver function and raises the risk of serious complications. Advanced liver disease may lead to jaundice, abdominal swelling, confusion, internal bleeding, liver failure, and liver cancer risk. Patients should understand that symptom severity does not always match liver damage severity.  Even if cannabis helps with sleep, pain, or nausea, it does not stop fibrosis progression or remove the virus itself. Protecting liver health still depends on proper antiviral treatment, medical follow-up, and ongoing monitoring.

3. The Most Important Message: Hepatitis C Is Usually Curable

3.1 Direct-Acting Antivirals

Modern hepatitis C treatment usually involves direct-acting antivirals (DAAs), oral medications that stop the virus from reproducing. Most patients complete treatment within eight to twelve weeks with high cure rates and fewer side effects than older therapies. Monitoring during treatment helps confirm the infection clears and supports improved long-term liver health.

3.2 Why patients should not delay HCV treatment

Delaying hepatitis C treatment allows liver inflammation and scarring to continue progressing over time. Some patients feel healthy for years and assume treatment is unnecessary, but liver damage may still develop quietly in the background. Early treatment lowers the risk of fibrosis, cirrhosis, liver cancer, and liver failure. Important reasons to seek timely hepatitis C treatment include:

• Reducing long-term liver damage and scarring
• Lowering the risk of cirrhosis and liver cancer
• Improving overall long-term health outcomes
• Decreasing the chance of spreading the virus to others
• Supporting better energy levels and quality of life after the cure

Even if symptoms seem mild, proper antiviral treatment remains one of the most important steps you can take to protect your future liver health and daily wellbeing.

3.3 Where Cannabis Fits

Cannabis may help some hepatitis C patients manage symptoms such as nausea, anxiety, sleep disruption, appetite loss, or chronic discomfort. However, it does not treat the virus itself. Patients should prioritize antiviral therapy, liver monitoring, and medical guidance while using cannabis cautiously as part of a broader liver health plan.

4. Can Medical Cannabis Treat Hepatitis C?

4.1 Cannabis is not an antiviral

Cannabis products are not proven to clear hepatitis C infection from the body. THC, CBD, and other cannabinoids may affect symptoms or mood, but they are not approved antiviral treatments for hepatitis C.  According to HCV Guidance from the AASLD AND IDSA, direct-acting antiviral therapy remains the recommended treatment for curing hepatitis C infection.  Patients should be cautious about websites or products claiming that cannabis can kill the virus or completely heal liver disease. Even patients who feel physically better after using cannabis may still have ongoing viral activity and liver inflammation that requires medical monitoring and follow-up testing.  

4.2 Symptom relief vs disease treatment

One of the most important distinctions patients should understand is the difference between symptom relief and actual disease treatment. Cannabis may help some patients sleep better, feel less nauseated, or improve appetite during difficult periods of illness or treatment. Those improvements may make daily life feel more manageable and comfortable. However, symptom improvement does not mean the virus has disappeared or that liver scarring has stopped progressing. Patients can still develop fibrosis, cirrhosis, or liver complications even while certain symptoms temporarily improve. This is why routine blood work, liver imaging, and proper antiviral care remain essential throughout hepatitis C treatment and recovery.

4.3 How to avoid misleading claims

Patients should carefully evaluate products or advertisements making unrealistic medical promises. Warning signs often include phrases such as:

• Liver cleanse
• Viral detox
• Natural hepatitis cure
• Guaranteed liver healing
• Cannabis antiviral treatment

These claims are often unsupported and may delay proper medical care. Reliable cannabis discussions should focus on symptom support, medication safety, product quality, and realistic expectations. If a company claims cannabis alone can cure hepatitis C, patients should view that as a major warning sign rather than trustworthy medical advice.

5. Symptoms of Hepatitis C That Patients Commonly Ask About

5.1 Fatigue and low energy

Fatigue is one of the most common complaints among hepatitis C patients. Some people describe it as constant exhaustion that does not improve with normal rest. Others notice low motivation, poor concentration, or difficulty keeping up with daily responsibilities. Fatigue may result from the virus itself, chronic inflammation, sleep disruption, anemia, stress, or advanced liver disease. Cannabis may help certain patients relax or sleep more comfortably, which can indirectly improve energy levels during the day. However, some cannabis products may also increase grogginess or mental fog, especially when THC levels are high.  Patients experiencing severe fatigue should still receive proper medical evaluation because low energy can signal liver disease progression, depression, medication side effects, or other health conditions that require treatment.

5.2 Nausea, appetite changes, and weight loss

Many hepatitis C patients experience appetite changes, nausea, or unintentional weight loss at some point during illness or treatment. These symptoms may interfere with nutrition, hydration, and overall strength. Some patients ask about cannabis because certain cannabinoid products may help improve appetite or reduce nausea during difficult periods. Patients should still monitor symptoms carefully and avoid assuming every digestive issue comes directly from hepatitis C. Medical evaluation becomes especially important when symptoms are persistent or worsening. Patients should contact a healthcare professional if they experience:

• Rapid or unexplained weight loss
• Severe vomiting or dehydration
• Difficulty keeping food or fluids down
• Vomiting blood or dark material
• Yellowing of the eyes or skin

Cannabis may support comfort for some patients, but nutrition, hydration, and proper liver care still remain essential parts of treatment and recovery.

5.3 Pain, itching, brain fog, and sleep disruption

Hepatitis C patients sometimes report body aches, abdominal discomfort, itching, concentration problems, and poor sleep quality. These symptoms may stem from chronic inflammation, stress, medication effects, liver disease, or unrelated medical conditions. Brain fog may involve forgetfulness, slow thinking, or trouble focusing during normal activities. Some patients explore cannabis to improve relaxation or nighttime comfort, particularly when pain or anxiety interferes with sleep. Still, high THC products may worsen confusion, dizziness, or daytime grogginess in certain people, especially older adults or patients with cirrhosis. Persistent symptoms deserve proper medical evaluation rather than self-diagnosis alone.

6. Cannabis, the Liver, and Why Hepatitis C Patients Need Extra Caution

6.1 How cannabinoids are processed

Cannabinoids such as THC and CBD are processed partly through liver enzyme pathways. This matters because hepatitis C patients may already have inflammation or reduced liver function, affecting how substances move through the body.  According to a review published in Frontiers in Psychiatry, cannabinoids are metabolized through hepatic cytochrome P450 enzyme systems, which may influence how cannabis interacts with prescription medications and liver function.  Certain hepatitis C medications may also use similar metabolic pathways. Because of this, cannabis products may affect patients differently depending on liver health, medication use, dose strength, and product type. 

6.2 Why liver stage matters

Cannabis decisions may differ significantly depending on the stage of liver disease. A patient with mild fibrosis may tolerate certain products differently than someone with advanced cirrhosis or hepatic encephalopathy. Reduced liver function can increase sensitivity to THC-related side effects such as sedation, confusion, dizziness, and impaired coordination. Patients with advanced liver disease should be especially cautious with high-potency products, large edible doses, or frequent use. Important factors healthcare professionals often evaluate include:

• Presence of cirrhosis or liver failure
• History of confusion or encephalopathy
• Current liver enzyme levels
• Medication interactions
• Alcohol use history

Careful monitoring becomes increasingly important as liver disease progresses.

6.3 When to involve a liver specialist

Patients should strongly consider involving a liver specialist before using cannabis alongside multiple medications, transplant-related care, or advanced liver disease. This is especially important for people considering high-dose CBD products, concentrates, or edible formulations that undergo significant liver metabolism. A specialist can help review medication interactions, evaluate liver function, and determine whether certain cannabis products pose additional risks. Honest communication matters because healthcare professionals can provide safer guidance when they understand exactly which products, doses, and supplements patients use regularly.

7. THC, CBD, and Other Cannabinoids Explained

7.1 THC

THC is the main intoxicating cannabinoid found in cannabis. It is responsible for the feeling of being high and may affect mood, appetite, sleep, coordination, and perception. Some hepatitis C patients explore THC products for nausea, appetite support, or sleep problems during treatment or recovery. According to an educational overview from the National Institute on Drug Abuse, THC can impair coordination, reaction time, judgment, and cognitive performance, particularly at higher doses or in sensitive individuals. However, THC is not risk-free, especially for patients with liver disease or medication sensitivities.  Higher THC doses may increase anxiety, dizziness, impaired coordination, or confusion. Older adults and patients with cirrhosis may feel these effects more strongly because liver impairment can affect how substances are processed in the body.

7.2 CBD

CBD is a non-intoxicating cannabinoid that many patients view as gentler than THC. Some people use CBD products for relaxation, stress, discomfort, or sleep support without wanting intoxicating effects. Still, non-intoxicating does not automatically mean harmless, especially for patients with hepatitis C or advanced liver disease. Patients should understand several important concerns related to CBD use:

• CBD may affect liver enzyme levels in some patients
• CBD can interact with prescription medications
• High-dose products may increase side effect risks
• Product labeling may not always be accurate
• Some CBD products still contain measurable THC

Because hepatitis C patients often take multiple medications, CBD deserves careful review with a healthcare professional before regular use begins.

7.3 CBG, CBN, delta 8 THC, and minor cannabinoids

Minor cannabinoids such as CBG, CBN, and delta 8 THC are becoming increasingly common in dispensaries and online markets. Many products advertise these cannabinoids for sleep, relaxation, focus, or pain support, but research remains limited compared to THC and CBD. Patients should approach newer or poorly regulated products carefully. Some products may contain inaccurate labels, contaminants, or unexpected THC levels. Semi-synthetic cannabinoids and gas station cannabis products deserve extra caution because quality standards may vary widely.  Patients with liver disease should prioritize regulated products with clear testing information and avoid assuming newer cannabinoids are automatically safer simply because they are marketed as mild or natural.

8. Potential Benefits Patients May Be Seeking

8.1 Nausea support

Nausea can interfere with eating, hydration, sleep, and daily comfort for some hepatitis C patients. Certain cannabis products may help reduce nausea sensations or improve appetite during periods of illness or antiviral treatment. Some patients also report feeling more comfortable eating small meals after carefully dosed cannabis use. Still, patients should monitor symptoms closely and avoid ignoring serious digestive problems. Severe vomiting, dehydration, vomiting blood, or worsening jaundice always require medical evaluation. Cannabis may support symptom management for some individuals, but it should not delay proper assessment of concerning liver-related symptoms.

8.2 Appetite and weight support

Appetite loss and unintended weight changes are common concerns among hepatitis C patients, especially during periods of chronic illness or treatment-related stress. Some cannabis products may help patients feel more interested in food, maintain calorie intake, or reduce nausea that interferes with eating regularly. Helpful nutrition-focused strategies may include:

• Eating smaller meals more frequently throughout the day
• Choosing protein-rich foods to support strength and recovery
• Staying hydrated with water and electrolyte-containing fluids
• Avoiding heavy alcohol intake and highly processed foods
• Discussing nutrition goals with a healthcare professional

Cannabis may help support appetite for some patients, but balanced nutrition and proper liver care remain central parts of long-term health management.

8.3 Sleep, pain, mood, and relaxation

Many hepatitis C patients struggle with disrupted sleep, chronic discomfort, stress, or mood changes related to long-term illness. Some people report that carefully selected cannabis products help them relax more comfortably at night or feel calmer during stressful periods of treatment and recovery. Patients should still approach cannabis thoughtfully because higher THC doses may worsen anxiety, confusion, or daytime grogginess in certain individuals.  Cannabis may improve comfort for some patients, but it does not treat the underlying viral infection or repair liver damage. Responsible use focuses on symptom support while continuing proper medical treatment and ongoing liver monitoring.

9. Risks and Side Effects Patients Should Know

9.1 Short-term side effects

Cannabis can affect patients differently depending on dose, liver health, tolerance, and medication use. Some hepatitis C patients tolerate low doses well, while others experience unpleasant effects even with small amounts. Short-term side effects may appear more strongly in patients with cirrhosis, older adults, or people sensitive to THC. According to a clinical review published in The New England Journal of Medicine, short-term cannabis effects may include impaired coordination, altered judgment, anxiety, dizziness, and slowed reaction time, particularly with higher THC exposure.  Other common side effects may also include dry mouth, sleepiness, confusion, and increased heart rate. Patients should avoid driving or performing risky physical tasks after cannabis use, especially when using edibles. Working with an MMJ provider helps regulate dosing and minimize side effects.

9.2 Longer-term concerns

Long-term cannabis use may create challenges for certain patients, particularly when use becomes frequent or high-dose over time. Some people develop tolerance, meaning they need increasing amounts to feel the same effects. Others may experience withdrawal symptoms such as irritability, sleep disruption, reduced appetite, or restlessness after stopping regular use. Patients should also understand several important long-term concerns:

• Cannabis use disorder can develop in some individuals
• Smoking cannabis may irritate the lungs and airways
• High THC use may worsen anxiety in certain patients
• Motivation and concentration changes may occur with heavy use
• Memory and reaction time may remain affected after use

Responsible cannabis use involves monitoring both symptom relief and unwanted side effects over time.

9.3 Liver-specific concerns

Hepatitis C patients need additional caution because liver disease can change how cannabinoids and medications are processed. High-dose CBD products deserve particular attention because they have been linked to liver enzyme elevations in some patients. Risks may increase further when alcohol use, multiple medications, or advanced cirrhosis are involved. Patients with worsening jaundice, confusion, severe fatigue, or abnormal liver tests should discuss cannabis use with a healthcare professional promptly.  Products that seem mild for healthy individuals may affect patients with liver disease very differently. Careful monitoring and honest communication with clinicians become increasingly important as liver damage progresses.

10. Cannabis and Hepatitis C Medications

10.1 Why medication interactions matter

Many hepatitis C patients take more than antiviral medications alone. Some also use antidepressants, acid reducers, sleep medications, pain relievers, seizure medicines, blood thinners, HIV medications, or transplant-related drugs. Because cannabinoids are processed through liver enzyme systems, cannabis products may affect how other medications work inside the body. Interactions do not always mean cannabis must be avoided completely, but they do require careful review. Certain combinations may increase sedation, dizziness, liver stress, or medication side effects. Patients should never assume that over-the-counter CBD oils or dispensary products are automatically safe alongside prescription medications.

10.2 What to tell your clinician

Many patients hesitate to discuss cannabis honestly with healthcare providers, but accurate information helps clinicians provide safer guidance. Your healthcare team needs to understand exactly which products you use and how often. Important details to share include:

• Whether the product contains THC, CBD, or both
• The dose and frequency of use
• The method used, such as smoking, vaping, edibles, or tinctures
• Where the product was purchased
• Any supplements or nonprescription products you also use

Providing clear information helps healthcare professionals monitor for interactions and adjust care safely if needed.

10.3 Monitoring during HCV treatment

Hepatitis C treatment usually involves monitoring before, during, and after antiviral therapy. Healthcare providers often review medications, liver enzymes, viral levels, and possible side effects throughout treatment. Cannabis use should also be part of that medication review process, especially when THC or CBD products are used regularly. Patients should pay close attention to memory, treatment adherence, and follow-up appointments while using cannabis during antiviral therapy. Missing doses or forgetting appointments may affect treatment success. Responsible cannabis use means supporting comfort without interfering with antiviral treatment goals or ongoing liver monitoring.

11. CBD and Liver Enzyme Elevation

11.1 Why CBD deserves its own section

Many patients are interested in CBD because it does not usually cause the intoxicating effects linked to THC. Some people explore CBD products for relaxation, sleep support, or general comfort while managing hepatitis C symptoms and daily stress. For many patients, CBD may feel like a more approachable option when starting medical cannabis discussions. According to a consumer safety update from the U.S. Food and Drug Administration, CBD may affect liver enzyme levels and can interact with certain medications processed through the liver. This does not mean CBD is unsafe for every hepatitis C patient, but it does mean product selection and dosing deserve thoughtful attention. Patients with liver disease should discuss CBD openly with healthcare professionals so products can be used more safely alongside antiviral medications and overall liver care.

11.2 Who should be especially careful

Certain hepatitis C patients should approach CBD products with extra caution. Patients with cirrhosis, abnormal liver enzymes, transplant-related care, or multiple medications may face a higher risk of interactions or side effects. Heavy alcohol use may also increase concerns about liver stress when CBD is added regularly. Patients who should speak with a healthcare professional before using CBD include:

• People with moderate or advanced cirrhosis
• Patients with elevated ALT or AST liver enzymes
• Individuals taking multiple prescription medications
• Patients using transplant-related medications
• Pregnant patients or people trying to become pregnant

Careful monitoring becomes especially important when CBD doses increase or when products are used daily over long periods.

11.3 Questions to ask before using CBD

Patients interested in CBD should ask practical questions before starting regular use. It is reasonable to ask whether liver enzymes should be checked, whether current medications could interact with CBD, and what dose range may be safer for someone with liver disease. Patients should also ask how to recognize warning signs that CBD may be poorly tolerated. Worsening fatigue, nausea, dizziness, abnormal lab results, or increased confusion should prompt medical attention. Open communication helps healthcare professionals guide safer product selection and monitor for problems before they become more serious.

12. Choosing Safer Cannabis Products

12.1 Licensed dispensary products vs unregulated products

Product quality matters greatly for hepatitis C patients because contaminated or mislabeled products may create additional health risks. Licensed dispensary products are generally tested for potency, pesticides, heavy metals, mold, and residual solvents. This testing helps patients better understand what they are actually consuming. Unregulated products sold online, through informal sellers, or at gas stations may not meet the same safety standards. Labels may contain inaccurate THC or CBD amounts, and some products may include contaminants or synthetic cannabinoids. Patients with liver disease should be especially cautious because reduced liver function may increase sensitivity to harmful substances.

12.2 Reading a certificate of analysis

A certificate of analysis, often called a COA, provides laboratory testing information for a cannabis product. Patients do not need to become laboratory experts, but learning the basics can improve product safety and consistency. Helpful details patients should review include:

• THC and CBD potency levels
• Batch number and testing date
• Contaminant screening results
• Presence of mold or heavy metals
• Serving size information

Products without clear testing information should be approached cautiously, especially by patients managing chronic liver disease or multiple medications.

12.3 Avoiding risky products

Patients should avoid products that make unrealistic cure claims or have unclear ingredients and labeling. Unlabeled oils, unknown vape cartridges, and synthetic cannabinoids may contain harmful substances that increase risks for patients with liver disease. Gas station cannabinoids and poorly regulated online products warrant additional caution due to widely varying quality standards. Safer cannabis use starts with transparency, regulated testing, and careful product selection rather than marketing promises. Patients should prioritize consistency and safety over products advertised as extremely strong or fast-acting.

13. Methods of Use: Pros, Cons, and Liver Considerations

13.1 Inhalation

Inhaled cannabis includes smoking and vaporized products that enter the bloodstream quickly through the lungs. Many patients prefer inhalation because effects are often felt within minutes, making it easier to adjust doses gradually. Faster onset may help some patients manage nausea, appetite problems, or sudden discomfort more predictably. According to a 2022 review published in JAMA Network Open, inhaled cannabis allows cannabinoids to reach the bloodstream rapidly, which may support quicker symptom response for some patients.  Smoking may still irritate the lungs, especially in patients with respiratory conditions or long-term tobacco exposure. Patients should also avoid unregulated vape cartridges or products with unclear ingredients to reduce unnecessary health risks.

13.2 Edibles and capsules

Edibles and capsules work differently because cannabinoids pass through the digestive system and liver before entering the bloodstream. Effects usually take longer to appear, sometimes one to three hours after use, but may also last much longer than inhaled products. Some patients prefer this slower onset for nighttime symptom support or longer-lasting relief. Patients should understand several important concerns with edibles and capsules:

• Delayed onset increases the risk of taking too much too quickly
• Effects may last longer than expected
• High THC doses may cause intense intoxication
• Liver metabolism plays a larger role with edible products
• Consistent serving sizes matter greatly for safe dosing

Patients with liver disease should approach edibles carefully and start with very low doses until they understand how their body responds.

13.3 Tinctures, oils, topicals, and patches

Tinctures and oils are often placed under the tongue or swallowed, depending on the product. Some patients prefer them because dosing may feel more controlled compared to smoking or vaping. Topicals and patches are sometimes used for localized discomfort, although their effects differ from inhaled or edible products. Regardless of the method used, patients should still review labels carefully and choose regulated products with clear testing information. Product quality, cannabinoid concentration, and serving size remain important for hepatitis C patients because liver disease may increase sensitivity to both THC and CBD related effects.

14. Dosing Principles for Hepatitis C Patients

14.1 Start low and go slow

Hepatitis C patients should approach cannabis cautiously, especially if they are older adults, new users, or living with cirrhosis. Starting with very low doses gives the body time to respond gradually and reduces the risk of anxiety, dizziness, confusion, or severe intoxication. Patients with liver disease may feel effects more strongly than expected because metabolism can change as liver function declines. Increasing doses slowly also helps patients identify the lowest amount needed for symptom support. Taking too much too quickly is one of the most common reasons patients experience unpleasant cannabis related effects. Patience is especially important with edibles because delayed onset often leads patients to accidentally overconsume.

14.2 Keep a symptom and dose journal

Tracking symptoms and dosing patterns can help patients recognize what works well and what creates problems. A simple journal may improve communication with healthcare providers and make it easier to identify patterns involving sleep, appetite, nausea, or side effects. Helpful details to track may include:

• Product type and cannabinoid content
• Dose amount and time used
• Symptom relief after use
• Side effects such as dizziness or anxiety
• Changes in sleep, appetite, or mood

Patients using multiple products should also document whether cannabis affects concentration, balance, or medication adherence during hepatitis C treatment.

14.3 When to stop or reduce use

Patients should reduce or pause cannabis use if side effects begin outweighing potential benefits. Warning signs may include worsening anxiety, severe sleepiness, falls, vomiting, confusion, or difficulty functioning normally during the day. Hepatitis C patients should also seek medical attention if symptoms such as jaundice, dark urine, severe abdominal swelling, or mental confusion worsen after cannabis use. These symptoms may reflect liver disease progression rather than a simple cannabis reaction. Responsible use means recognizing when a product is no longer helping to keep people safe.

15. Special Safety Concerns for Cirrhosis

15.1 Compensated vs decompensated cirrhosis

Cirrhosis develops when extensive scar tissue replaces healthy liver tissue and interferes with normal liver function. Some patients have compensated cirrhosis, meaning the liver is still functioning relatively well despite significant scarring. Others develop decompensated cirrhosis, which involves serious complications such as fluid buildup, jaundice, confusion, or internal bleeding. Patients with decompensated cirrhosis require much greater caution with cannabis products because reduced liver function may increase sensitivity to THC and other substances. Sedation, dizziness, and mental confusion may appear more easily in advanced liver disease. Patients should never assume cannabis is automatically safe simply because it is being used for symptom support rather than recreation.

15.2 Cannabis and confusion risk

Patients with cirrhosis may already face a risk of hepatic encephalopathy, a condition involving confusion, memory problems, slowed thinking, or changes in alertness caused by advanced liver dysfunction. THC products, especially in higher doses, may worsen these symptoms in vulnerable patients. Important warning signs patients and caregivers should watch for include:

• New or worsening confusion
• Extreme sleepiness during the day
• Difficulty speaking clearly
• Poor balance or repeated falls
• Sudden personality or behavior changes

Patients experiencing these symptoms should contact a healthcare professional promptly. In advanced liver disease, even moderate cannabis doses may affect thinking and coordination more strongly than expected.

15.3 Liver cancer surveillance

Patients with cirrhosis often require ongoing liver cancer surveillance even after hepatitis C is successfully treated. Healthcare providers may recommend regular ultrasound imaging and blood testing every six months to monitor for early signs of liver cancer. Cannabis does not replace this monitoring process or reduce the need for continued liver care. Some patients feel physically better after antiviral treatment or cannabis supported symptom management, but underlying cirrhosis may still require lifelong follow-up. Staying engaged with liver specialists and routine screenings remains one of the most important parts of protecting long-term health.

16. Cannabis, Alcohol, and Hepatitis C

16.1 Why alcohol is a major liver risk

Alcohol is one of the most harmful substances for patients living with hepatitis C or cirrhosis. Even moderate alcohol use may accelerate liver inflammation, fibrosis, and long term liver damage. Patients who continue drinking heavily while living with hepatitis C face a significantly higher risk of cirrhosis, liver failure, and liver cancer. Some patients ask whether cannabis may help reduce alcohol use or support relaxation during recovery from drinking. While individual experiences vary, patients should still focus on evidence based liver protection strategies that prioritize reducing or avoiding alcohol whenever possible.

16.2 Do not use cannabis as a reason to keep drinking

Patients should avoid viewing cannabis as a protective shield against alcohol related liver damage. Cannabis does not cancel out the harmful effects of alcohol on the liver, especially in people already living with hepatitis C or cirrhosis. Healthier liver-focused strategies may include:

• Reducing or stopping alcohol intake completely
• Seeking counseling or addiction support when needed
• Building healthier sleep and stress management routines
• Maintaining regular medical follow-up and liver monitoring
• Discussing substance use honestly with healthcare providers

Open conversations about alcohol and cannabis help clinicians provide safer and more realistic guidance without judgment.

16.3 Cross-fading risks

Using cannabis and alcohol together, often called cross-fading, may increase impairment much more than using either substance alone. Patients may experience stronger dizziness, vomiting, poor judgment, slowed reaction time, or severe sedation when both substances are combined. For hepatitis C patients with advanced liver disease, these risks may become even more serious because balance problems, confusion, and falls can lead to dangerous complications. Patients should approach combined use very cautiously and understand that alcohol remains one of the most significant threats to long-term liver health.

17. Cannabis Use During Hepatitis C Treatment

17.1 Before starting antivirals

Before beginning hepatitis C antiviral treatment, patients should review all medications, supplements, and cannabis products with their healthcare provider. This includes THC products, CBD oils, edibles, tinctures, and over-the-counter supplements that may affect liver enzymes or interact with antiviral medications. Honest communication helps clinicians identify possible risks early and create a safer treatment plan. Healthcare providers may also review liver function, mental health history, pregnancy considerations, alcohol use, and other medical conditions before treatment begins. Patients using cannabis regularly should discuss whether certain products could interfere with memory, medication adherence, or side effect monitoring during antiviral therapy.

17.2 During antiviral therapy

During hepatitis C treatment, medication adherence becomes extremely important because missed doses may reduce treatment success. Some patients continue using cannabis during therapy to help with appetite, nausea, sleep problems, or stress related to illness. When used responsibly, cannabis may help certain patients remain more comfortable throughout treatment. Patients should still monitor themselves carefully during antiviral therapy. Important areas to pay attention to include:

• Remembering daily medication schedules
• Attending follow-up appointments consistently
• Monitoring side effects and liver-related symptoms
• Avoiding excessive THC intoxication
• Reporting new symptoms promptly to clinicians

Cannabis should support treatment adherence rather than interfere with focus, coordination, or medical follow-up during therapy.

17.3 After cure

Many patients feel relieved after completing treatment and achieving sustained virologic response, which means hepatitis C is no longer detected after therapy. Even after a cure, some people continue dealing with fatigue, chronic pain, anxiety, sleep disruption, or liver scarring from previous damage. Patients with advanced fibrosis or cirrhosis may still require long-term liver monitoring even after the virus is cured. Cannabis considerations may also differ after treatment depending on overall liver recovery. Some patients tolerate cannabinoids better once inflammation improves, while others still require ongoing caution because of permanent liver damage or medication use.

18. Mental Health, Stigma, and Medical Cannabis

18.1 Anxiety, depression, trauma, and chronic illness

Living with hepatitis C may affect emotional health as much as physical health. Some patients carry anxiety, depression, shame, or past healthcare trauma related to chronic illness, substance use history, or delayed diagnosis. Ongoing fatigue and physical symptoms may also increase stress and isolation over time. Some patients explore cannabis because they feel it helps them relax or cope emotionally during difficult periods. While symptom support matters, emotional well-being should still be addressed through broader mental health care when needed. Counseling, support groups, and integrated healthcare approaches often play an important role alongside physical treatment.

18.2 When cannabis may worsen symptoms

Cannabis does not affect mental health the same way for every patient. Some individuals feel calmer with low-dose products, while others experience panic, paranoia, racing thoughts, or worsening anxiety after THC exposure. Patients with prior mental health conditions may be especially sensitive to high-potency cannabis products. Patients should watch carefully for symptoms such as:

• Increased panic or anxiety after use
• Paranoia or severe suspicious thinking
• Mood instability or emotional withdrawal
• Memory problems or worsening concentration
• Difficulty functioning normally during the day

These symptoms may signal that the product, dose, or THC level is not appropriate for the individual patient.

18.3 Support beyond cannabis

Cannabis may help some patients feel more comfortable, but it should not become the only source of emotional support during hepatitis C treatment or recovery. Long-term well-being often improves most when patients combine symptom management with mental health care, healthy sleep habits, social support, and regular medical follow-up. Support may come from counselors, peer support programs, addiction specialists, sleep clinics, or liver care teams familiar with chronic illness. Patients deserve compassionate care that addresses both emotional health and physical symptoms without judgment or unrealistic promises about cannabis alone solving every problem.

19. Pain Management for Hepatitis C Patients

19.1 Types of pain patients may experience

Hepatitis C patients may experience several different forms of pain depending on liver health, inflammation levels, treatment history, and unrelated medical conditions. Some people report joint pain, muscle aches, headaches, abdominal discomfort, or nerve-related symptoms such as tingling and burning sensations. Chronic fatigue and poor sleep may also increase the intensity of pain throughout the body. Not every pain symptom is directly caused by hepatitis C. Arthritis, back injuries, neuropathy, stress, and other chronic conditions may contribute as well. Proper medical evaluation remains important because persistent or severe pain may require treatment beyond cannabis alone, especially when liver disease limits the safe use of certain medications.

19.2 Cannabis as part of a broader plan

Some hepatitis C patients explore cannabis because they want additional pain management options that may help reduce discomfort and improve daily functioning. Certain products may support relaxation, improve sleep quality, or make chronic pain feel more manageable for some individuals. Pain management usually works best when cannabis is combined with broader supportive strategies such as:

• Physical therapy and gentle movement routines
• Better sleep habits and stress reduction
• Medication review for safer pain control
• Nutrition and hydration support
• Ongoing liver monitoring and medical follow-up

Patients should focus on improving quality of life safely rather than chasing complete symptom elimination through higher cannabis doses.

19.3 Avoiding unsafe self-treatment

Patients should avoid combining cannabis with opioids, benzodiazepines, alcohol, or other sedating substances without medical guidance. These combinations may increase the risk of severe sedation, impaired coordination, confusion, breathing problems, or dangerous falls, especially in patients with cirrhosis or advanced liver disease. Self-treating severe pain without medical evaluation may also delay diagnosis of serious liver complications or unrelated health conditions. Responsible cannabis use means recognizing its limitations and involving healthcare professionals when symptoms worsen, become disabling, or interfere with normal daily activities.

20. Nausea, Appetite, and Weight Loss

20.1 When appetite support is appropriate

Appetite problems are common among hepatitis C patients, especially during periods of chronic illness, stress, antiviral treatment, or advanced liver disease. Some patients struggle to maintain regular meals because nausea, abdominal discomfort, or fatigue reduces interest in food. In these situations, carefully selected cannabis products may help certain people improve appetite or tolerate meals more comfortably. Patients should still monitor symptoms closely because severe appetite loss and ongoing nausea may signal worsening liver problems or medication-related side effects. Cannabis may support comfort for some individuals, but it should not replace proper evaluation when symptoms become persistent or severe.

20.2 Nutrition priorities

Nutrition plays an important role in maintaining strength, muscle mass, hydration, and overall liver health during hepatitis C treatment and recovery. Many patients benefit from eating smaller meals more frequently rather than forcing large meals during periods of nausea or low appetite. Helpful nutrition priorities may include:

• Choosing protein-rich foods to support recovery
• Drinking enough fluids throughout the day
• Eating balanced meals with fruits and vegetables
• Limiting alcohol and heavily processed foods
• Following cirrhosis-related nutrition guidance if prescribed

Patients with advanced liver disease may also require individualized nutrition recommendations from healthcare professionals familiar with cirrhosis care.

20.3 Red flags

Patients should seek medical attention when nausea, vomiting, or weight loss become severe or rapidly worsen. Certain symptoms may indicate serious liver complications or gastrointestinal bleeding rather than routine appetite changes. Warning signs include vomiting blood, black stools, severe abdominal swelling, inability to keep fluids down, rapid weight loss, worsening jaundice, or increasing weakness. Cannabis should never delay emergency medical care when these symptoms appear. Early medical evaluation may prevent dangerous complications and improve treatment outcomes.

21. Sleep Problems and Fatigue

21.1 Why fatigue is complicated

Fatigue in hepatitis C patients is often more complex than simple tiredness. Some people feel physically drained throughout the day, while others struggle with poor concentration, low motivation, or heavy daytime sleepiness. Fatigue may result from chronic liver inflammation, anemia, poor sleep quality, depression, medication side effects, or advanced cirrhosis. Patients sometimes assume hepatitis C is the only reason for their exhaustion, but many overlapping factors may contribute. Sleep apnea, anxiety, chronic pain, poor nutrition, and even excessive cannabis use may worsen daytime fatigue. Understanding the cause matters because treatment approaches may differ depending on what is driving the symptoms.

21.2 Cannabis for sleep

Some hepatitis C patients explore cannabis products because sleep disruption affects mood, energy, pain tolerance, and overall quality of life. Certain patients report falling asleep more easily or feeling more relaxed at bedtime after using carefully selected products. Lower dose cannabis products may help some individuals unwind without severe next day grogginess. Patients should still approach cannabis for sleep cautiously and monitor how products affect them over time. Important considerations include:

• THC may cause next day grogginess in some patients
• Higher doses may increase confusion or dizziness
• Tolerance can develop with frequent nighttime use
• CBD and THC may affect patients differently
• Sleep hygiene still matters alongside cannabis use

Good bedtime routines, stress management, and consistent sleep schedules remain important even when cannabis is part of symptom support.

21.3 When to seek medical evaluation

Patients should seek medical evaluation if fatigue becomes severe, worsens suddenly, or significantly interferes with daily life. Confusion, memory problems, worsening depression, loud snoring, breathing pauses during sleep, or extreme daytime sleepiness may signal conditions that require medical attention beyond cannabis related symptom support. In patients with cirrhosis, worsening fatigue or confusion may also reflect hepatic encephalopathy or liver disease progression. Responsible cannabis use includes recognizing when symptoms need professional evaluation rather than repeated dose increases or self-treatment alone.

22. Caregiver Guidance

22.1 How caregivers can help safely

Caregivers often play an important role in helping hepatitis C patients manage medications, appointments, symptom tracking, and daily routines. Family members may also notice side effects or mental changes before the patient fully recognizes them. Supportive involvement can improve treatment adherence and help patients feel less overwhelmed during difficult periods. Caregivers may help by organizing medication lists, documenting symptoms, monitoring side effects, and assisting with transportation to appointments. Patients using cannabis may especially benefit from help tracking product types, doses, and possible reactions over time. Support should remain respectful and focused on patient safety rather than judgment or control.

22.2 Recognizing urgent liver symptoms

Caregivers should understand the warning signs that may indicate worsening liver disease or a medical emergency. Advanced hepatitis C complications can progress quickly, especially in patients with cirrhosis or hepatic encephalopathy. Important symptoms requiring prompt medical attention include:

• New or worsening confusion
• Vomiting blood or black stools
• Severe abdominal swelling
• Yellowing of the eyes or skin
• Sudden weakness or difficulty staying awake

Early recognition of these symptoms may help patients receive treatment before complications become life-threatening.

22.3 Respecting patient autonomy

Patients deserve honest conversations and support without pressure, shame, or fear-based decision-making. Caregivers may have concerns about cannabis use, but respectful communication usually works better than confrontation or criticism. Many patients are more likely to discuss symptoms and side effects openly when they feel supported rather than judged. Helping patients communicate honestly with healthcare professionals also improves safety. Caregivers can encourage questions, assist with medical visits, and support informed decision-making while still respecting the patient’s independence and personal healthcare choices.

23. Legal, Workplace, and Travel Considerations

23.1 Medical cannabis laws vary

Medical cannabis laws differ widely depending on the state, country, and local regulations where a patient lives. Some areas allow broad medical access through licensed dispensaries, while others restrict qualifying conditions, product types, or possession limits. Patients should understand the laws that apply specifically to their location before purchasing or carrying cannabis products. Hepatitis C patients should also remember that legal medical cannabis access does not automatically mean every product is medically appropriate. A recommendation from a healthcare professional should still include discussion about liver health, medication interactions, dosing safety, and realistic treatment goals. 

23.2 Employment and drug testing

Patients should understand that cannabis laws do not always protect employment status or workplace drug testing policies. Even legal CBD products may contain enough THC to trigger a positive drug test, especially with frequent use or poorly labeled products. This can create problems for patients working in healthcare, transportation, law enforcement, or other safety-sensitive fields. Important workplace concerns may include:

• Positive THC tests from mislabeled CBD products
• Employer-specific drug testing policies
• Safety restrictions involving machinery or driving
• Delayed impairment after edible cannabis use
• Limited legal protections in some workplaces

Patients should carefully review workplace policies and avoid assuming medical cannabis automatically protects them from employment consequences.

23.3 Travel safety

Traveling with cannabis requires caution because laws change across state lines, airports, and international borders. A product that is legal in one location may create legal problems in another, even if purchased from a licensed dispensary. Patients should avoid carrying cannabis across international borders unless laws clearly allow it. They should also remember that THC impairment may affect driving safety during long trips. Planning ahead, understanding local laws, and avoiding unnecessary legal risks can help patients travel more safely while managing hepatitis C and medical cannabis use responsibly.

24. Talking to Your Doctor About Cannabis

24.1 What to bring to the visit

Patients often feel nervous discussing cannabis with healthcare professionals, especially when they worry about judgment or misunderstanding. However, honest communication gives clinicians the information needed to provide safer guidance, monitor for interactions, and help patients avoid preventable complications. Bringing clear information to appointments can make these conversations much easier. Helpful items may include product labels, dose information, supplement lists, recent lab results, and notes about symptoms or side effects. Patients should also mention how often they use cannabis and whether products contain THC, CBD, or both.

24.2 Questions to ask

Patients should feel comfortable asking direct questions about cannabis safety and liver health. Open discussions often help clarify realistic expectations while reducing confusion caused by online misinformation or aggressive product marketing. Helpful questions may include:

• Is this product safe with my liver condition?
• Could cannabis interact with my hepatitis C medications?
• Should my liver enzymes be monitored more closely?
• What THC or CBD dose range is safer for me?
• Are there product types I should avoid completely?

These conversations help patients make more informed decisions while keeping long-term liver health in focus.

24.3 How to be honest without fear

Many patients avoid discussing cannabis because they fear criticism or stigma. In reality, healthcare professionals can usually provide safer care when they understand exactly what products a patient is using. Hidden cannabis use may increase the risk of medication interactions, side effects, or confusion during hepatitis C treatment. Patients do not need to present themselves perfectly to deserve compassionate medical care. Honest conversations about cannabis, alcohol use, supplements, and symptoms allow clinicians to focus on practical safety rather than assumptions. Clear communication often leads to better support, better monitoring, and safer long-term health decisions.

25. Patient Decision Checklist

25.1 Before trying cannabis

Patients should take time to evaluate their overall hepatitis C care plan before starting cannabis. Understanding your liver stage, medication list, treatment status, and symptom goals helps create a safer foundation for decision-making. Cannabis may support certain symptoms, but it works best when combined with proper liver care and realistic expectations. Before trying cannabis, patients should review several important safety areas:

• Confirm current hepatitis C treatment and follow-up plans
• Know whether cirrhosis or advanced fibrosis is present
• Review medications and supplements for interactions
• Choose products from regulated and tested sources
• Identify clear symptom goals instead of vague expectations

Careful preparation reduces confusion and helps patients approach cannabis in a more informed and responsible way.

25.2 During use

Once cannabis use begins, patients should continue monitoring how products affect symptoms, daily functioning, and overall health. A product that initially feels helpful may later cause unwanted side effects, especially if doses increase over time or liver disease progresses. Tracking symptoms also helps healthcare professionals provide more accurate guidance. Patients should pay attention to changes involving sleep, appetite, mood, concentration, dizziness, balance, and liver-related symptoms. Keeping a simple journal of products, doses, and effects may make it easier to identify patterns. Responsible use involves ongoing observation rather than assuming the same product or dose will always remain appropriate.

25.3 Reasons to pause and call a clinician

Patients should stop or reduce cannabis use and contact a healthcare professional if concerning symptoms develop. Some side effects may reflect excessive THC exposure, while others could signal worsening liver disease or dangerous medication interactions. Warning signs that deserve medical attention include:

• New confusion or worsening mental fog
• Severe anxiety, panic, or paranoia
• Falls, poor coordination, or extreme sedation
• Vomiting, jaundice, or dark urine
• Rapid abdominal swelling or abnormal lab results

Seeking help early may prevent more serious complications and improve long-term safety.

26. Myths and Misconceptions

26.1 “Cannabis cures hepatitis C”

One of the most common myths patients encounter online is the claim that cannabis can cure hepatitis C naturally. Current medical evidence does not support this claim. THC, CBD, and other cannabinoids are not proven antiviral treatments for clearing hepatitis C infection from the body. Patients should understand that symptom relief and viral cure are not the same thing. A patient may feel less nauseated or sleep better after using cannabis while the virus continues to damage liver tissue silently in the background. Proper antiviral treatment remains the only proven method for curing hepatitis C.

26.2 “CBD is always safe because it is natural”

Many patients assume CBD products are completely harmless because they are marketed as natural wellness products. In reality, CBD may still cause side effects, affect liver enzymes, and interact with medications commonly used by hepatitis C patients. Important realities patients should remember include:

• CBD can interact with prescription medications
• High doses may affect liver function tests
• Product labels are not always accurate
• Some CBD products contain measurable THC
• Liver disease may increase sensitivity to side effects

Natural products still require careful use, especially in patients with chronic liver disease or multiple medications.

26.3 “If cannabis helps symptoms, my liver must be healing”

Symptom improvement does not automatically mean the liver is recovering or that hepatitis C is cured. Cannabis may temporarily reduce nausea, improve sleep, or support appetite without changing the underlying viral infection or liver scarring process. Patients may still develop fibrosis, cirrhosis, or liver cancer even when symptoms feel more manageable. This is why ongoing medical follow-up, liver monitoring, and antiviral treatment remain essential parts of long-term hepatitis C care.

27. FAQs About Medical Cannabis and Hepatitis C

Many hepatitis C patients have practical questions about medical cannabis that may not come up during routine appointments. These quick answers address everyday concerns involving safety, lifestyle, treatment, and responsible cannabis use.

27.1 Can medical cannabis affect my appetite too much?

Some patients experience increased hunger after using THC products, which may help during periods of poor appetite or weight loss. However, overeating highly processed foods may worsen energy levels and overall health. Patients should focus on balanced nutrition, hydration, and portion awareness while using cannabis for appetite support.

27.2 Should I avoid cannabis during liver imaging or blood work appointments?

Patients usually do not need to completely avoid cannabis before routine liver imaging or blood tests unless instructed otherwise by a healthcare professional. However, arriving intoxicated may affect communication, memory, coordination, or symptom reporting during appointments. Clear communication and accurate medical information remain important during liver evaluations.

27.3 Can cannabis affect motivation during hepatitis C recovery?

High THC products may reduce motivation, concentration, or daily productivity in some patients, especially with heavy or frequent use. Patients recovering from hepatitis C often benefit from maintaining routines involving exercise, nutrition, sleep, and follow up care. Cannabis should support recovery goals rather than interfere with normal daily functioning.

27.4 Is it safer to use cannabis only at night?

Some patients prefer nighttime cannabis use because it may reduce daytime grogginess, dizziness, or concentration problems. Evening use may also help patients who mainly seek sleep or relaxation support. Still, nighttime dosing can sometimes cause next-day sedation, especially with high THC edibles or excessive dosing.

27.5 What should I do if a cannabis product feels too strong?

Patients who feel overwhelmed after cannabis use should stay calm, hydrate, and rest in a safe environment. Effects usually improve with time. Avoid mixing cannabis with alcohol or additional substances. Patients experiencing chest pain, severe confusion, breathing difficulty, or dangerous behavior should seek emergency medical attention immediately.

States Where This Condition Qualifies for Medical Marijuana

Hepatitis C Symptom Support With DocMJ

At DocMJ, we help patients explore medical cannabis options for symptoms related to hepatitis C, including nausea, sleep problems, appetite changes, and chronic discomfort. Our team provides medical marijuana evaluations and guidance focused on safe, informed, and compassionate care. Schedule your consultation today!

Citations

1. American Association for the Study of Liver Diseases & Infectious Diseases Society of America. (2023). HCV guidance: Recommendations for testing, managing, and treating hepatitis C. https://www.hcvguidelines.org/evaluate/testing-and-linkage
2. Centers for Disease Control and Prevention. (2025, August 29). Clinical overview of viral hepatitis. U.S. Department of Health and Human Services. https://www.cdc.gov/hepatitis/hcp/clinical-overview/index.html
3. Gedin F, Blomé S, Pontén M, et al. Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(11):e2243848. doi:10.1001/jamanetworkopen.2022.43848
4. Kocis, P. T., & Vrana, K. E. (2022). Delta-9-tetrahydrocannabinol and cannabidiol drug drug interactions. Frontiers in Psychiatry, 13, 1055481. https://doi.org/10.3389/fpsyt.2022.1055481
5. U.S. Food and Drug Administration. (2023). What you need to know and what we’re working to find out about products containing cannabis or cannabis-derived compounds, including CBD. https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis
6. Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2020). Adverse health effects of marijuana use. The New England Journal of Medicine, 370(23), 2219–2227. https://doi.org/10.1056/NEJMra1402309